FGF23 and chronic kidney disease: In addition, hyperphosphatemia is associated with VC in animal models of CKD, and mice with targeted deletion of FGF23 or klotho show hyperphosphatemia and VC (Stubbs et al., 2007; El-Abbadi et al., 2009; Giachelli, 2009).